These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13523)

  • 21. The role of antibody in rat renal allograft rejection. I. Absence of antibody to erythrocyte-associated antigens is associated with enhanced renal allograft survival.
    Majoor GD; van de Gaar MJ; Vlek LF; van Breda Vriesman PJ
    Transplantation; 1981 May; 31(5):369-75. PubMed ID: 7015624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Demonstration of blocking factors in permanently surviving rat-kidney allograft recipients after short postoperative treatment with alloantiserums].
    Lie TS; Kanda M; Ehlenz H; Kim WI; Holst A; Biersack HJ
    Langenbecks Arch Chir; 1976; Suppl():6-10. PubMed ID: 801562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated pancreatic islet allografts in rats rendered immunologically unresponsive to renal allografts. The effect of the site of transplantation.
    Gray DW; Reece-Smith H; Fairbrother B; McShane P; Morris PJ
    Transplantation; 1984 May; 37(5):434-7. PubMed ID: 6233763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat].
    Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival of cardiac allografts in lethally irradiated rats repopulated with host-type hemopoietic cells.
    Dittmer J; Bennett M
    Transplantation; 1975 Apr; 19(4):295-301. PubMed ID: 239473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
    Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
    Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Suppression of the cell-mediated immunity in minor histoincompatible rat kidney allograft recipients (author's transl)].
    Lie TS; Kanda M; Choi SK; Piepho A; Grünn U; Oehr P
    Res Exp Med (Berl); 1977 Sep; 171(2):141-53. PubMed ID: 337427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
    Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
    Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active enhancement of rat renal allografts with papain-released specific antigens.
    von Haefen U; Wren SF; Shaipanich T; Martins AC; Busch GJ; Wilson RE
    Transplantation; 1973 Oct; 16(4):295-303. PubMed ID: 4126788
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.
    Langrehr JM; Hoffman RA; Demetris AJ; Lee KK; Neuhaus P; Wren SM; Ildstad ST; Schraut WH
    Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.